Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.66 - $0.91 $534 - $737
-810 Reduced 5.74%
13,290 $11,000
Q3 2023

Nov 13, 2023

SELL
$0.85 - $1.43 $9,265 - $15,587
-10,900 Reduced 43.6%
14,100 $12,000
Q2 2023

Aug 09, 2023

BUY
$1.12 - $1.49 $28,000 - $37,250
25,000 New
25,000 $29,000
Q4 2022

Feb 13, 2023

BUY
$1.07 - $1.34 $21,400 - $26,800
20,000 New
20,000 $24,000
Q2 2022

Aug 11, 2022

SELL
$1.13 - $3.69 $3,389 - $11,070
-3,000 Reduced 2.0%
147,000 $219,000
Q1 2022

May 13, 2022

SELL
$2.85 - $3.73 $28,500 - $37,300
-10,000 Reduced 6.25%
150,000 $494,000
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $66,980 - $99,280
-17,000 Reduced 9.6%
160,000 $816,000
Q1 2021

May 12, 2021

SELL
$5.03 - $8.8 $65,390 - $114,400
-13,000 Reduced 6.84%
177,000 $1.1 Million
Q4 2020

Feb 12, 2021

SELL
$4.04 - $5.31 $241,390 - $317,272
-59,750 Reduced 23.92%
190,000 $929,000
Q3 2020

Nov 13, 2020

BUY
$3.64 - $7.76 $205,660 - $438,440
56,500 Added 29.24%
249,750 $1.05 Million
Q2 2020

Aug 13, 2020

SELL
$4.78 - $8.26 $51,385 - $88,795
-10,750 Reduced 5.27%
193,250 $1.34 Million
Q1 2020

May 12, 2020

BUY
$4.0 - $21.53 $216,000 - $1.16 Million
54,000 Added 36.0%
204,000 $816,000
Q4 2019

Feb 12, 2020

BUY
$13.94 - $24.12 $2.09 Million - $3.62 Million
150,000 New
150,000 $3.22 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Dcf Advisers, LLC Portfolio

Follow Dcf Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.